Insulin detemir results in less weight gain than NPH insulin when added to oral agents in type 2 diabetes, with this advantage increasing with baseline obesity

被引：0
|
作者：
Hermansen, K
Tamer, SC
机构：
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[2] Novo Nordisk, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：A4 / A5
页数：2
相关论文
共 50 条
  • [41] Insulin is associated with less weight gain in well-controlled type 2 diabetes
    Huizinga, Mary Margaret
    Niswender, Kevin
    Gebretsadik, Tebeb
    Rothman, Russell
    Shintani, Ayumi
    Elasy, Tom A.
    DIABETES, 2007, 56 : A8 - A8
  • [42] Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study
    Yale, Jean-Francois
    Damci, Taner
    Kaiser, Marcel
    Karnieli, Eddy
    Khunti, Kamlesh
    Liebl, Andreas
    Baeres, Florian M. M.
    Svendsen, Anne Louise
    Ross, Stuart A.
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [43] Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study
    Jean-François Yale
    Taner Damci
    Marcel Kaiser
    Eddy Karnieli
    Kamlesh Khunti
    Andreas Liebl
    Florian MM Baeres
    Anne Louise Svendsen
    Stuart A Ross
    Diabetology & Metabolic Syndrome, 5
  • [44] How do detemir and glargine compare when added to oral agents in insulin-naive patients with type 2 diabetes mellitus? (vol 4, pg 490, 2008)
    Marks, Jennifer B.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (12): : 702 - 702
  • [45] ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN
    Pfohl, M.
    Dippel, F. W.
    Kostev, K.
    Kotowa, W.
    VALUE IN HEALTH, 2008, 11 (06) : A509 - A510
  • [46] Starting insulin for type 2 diabetes with insulin glargine added to oral agents vs twice-daily premixed insulin alone
    Janka, H
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETES, 2004, 53 : A130 - A130
  • [47] Starting insulin for Type 2 diabetes with insulin glargine added to oral agents versus twice-daily premixed insulin alone
    Janka, HU
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETOLOGIA, 2004, 47 : A269 - A270
  • [48] Modeling the cost-utility of reduced hypoglycemia and weight gain among type 2 diabetes patients newly initiated on basal insulin: A case study of detemir and NPH
    Valentine, W
    Cobden, D
    Palmer, A
    Roze, S
    VALUE IN HEALTH, 2006, 9 (03) : A36 - A36
  • [49] PS1 - 1. Insulin detemir increases cerebral glucose metabolism compared to NPH insulin in human type 1 diabetes: possible explanation for differences in weight gain?
    Larissa W. van Golen
    Marc C. Huisman
    Richard G. IJzerman
    Nikie J. Hoetjes
    Lothar A. Schwarte
    Patrick Schober
    Roel P. Hoogma
    Madeleine L. Drent
    Adriaan A. Lammertsma
    Michaela Diamant
    Nederlands Tijdschrift voor Diabetologie, 2011, 9 (3) : 91 - 91
  • [50] Combination-therapy with bedtime NPH insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes
    Olsson, PO
    Lindström, T
    DIABETES & METABOLISM, 2002, 28 (04) : 272 - 277
12345